{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:41:17Z","timestamp":1771594877899,"version":"3.50.1"},"reference-count":50,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Haemophilia A (HA) is an X-linked bleeding disorder caused by the deficiency or dysfunction of coagulation factor VIII (FVIII). Substitution therapy with recombinant or plasma-derived FVIII effectively restores haemostasis but carries the risk of eliciting FVIII-specific neutralizing antibodies known as inhibitors. Inhibitor formation reflects the absence of central immune tolerance, driven by complex interactions among antigen-presenting cells, B cells and CD4 T cell subsets. Recent studies highlight the essential roles of T cell polarization, costimulatory signalling and cytokine networks in shaping the immunogenic or tolerogenic outcome of FVIII exposure. This review summarizes mechanistic insights into how distinct CD4 T cell subpopulations, including Th1, Th2, Th17, follicular helper (Tfh), follicular regulatory (Tfr) and regulatory T cells (Tregs), influence inhibitor development in HA. Furthermore, it discusses emerging immunological concepts and cellular pathways that could be targeted to achieve durable tolerance towards FVIII, with emphasis on translational strategies that align mechanistic understanding with clinical need.<\/jats:p>","DOI":"10.1055\/a-2748-8775","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T23:30:27Z","timestamp":1771371027000},"page":"017-023","source":"Crossref","is-referenced-by-count":1,"title":["Immune Response Mechanisms in Haemophilia A"],"prefix":"10.1055","volume":"46","author":[{"given":"Amina","family":"Abdelmageed","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine and Experimental Immunology, University Clinic Bonn, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clivia","family":"Lisowski","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine and Experimental Immunology, University Clinic Bonn, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1190-2133","authenticated-orcid":false,"given":"Janine","family":"Becker-Gotot","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine and Experimental Immunology, University Clinic Bonn, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.blre.2018.02.003","article-title":"Review of immune tolerance induction in hemophilia A","volume":"32","author":"S J Schep","year":"2018","journal-title":"Blood Rev"},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood-2014-08-535328","article-title":"FVIII inhibitors: pathogenesis and avoidance","volume":"125","author":"J Astermark","year":"2015","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fimmu.2019.02991","article-title":"Tolerating factor VIII: recent progress","volume":"10","author":"S Lacroix-Desmazes","year":"2020","journal-title":"Front Immunol"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2012-07-444877","article-title":"Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients","volume":"121","author":"S FJ Whelan","year":"2013","journal-title":"Blood"},{"issue":"08","key":"ref5","first-page":"e5442","article-title":"Acquired hemophilia A: a rare but potentially fatal bleeding disorder","volume":"11","author":"A S Yousphi","year":"2019","journal-title":"Cureus"},{"issue":"07","key":"ref6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood-2014-09-598268","article-title":"Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans","volume":"125","author":"C J Hofbauer","year":"2015","journal-title":"Blood"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"L Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0038-1650515","article-title":"T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors","volume":"76","author":"S T Singer","year":"1996","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ajh.2830420408","article-title":"Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort Study","volume":"42","author":"G L Bray","year":"1993","journal-title":"Am J Hematol"},{"issue":"21","key":"ref10","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1182\/bloodadvances.2017008706","article-title":"CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise na\u00efve and memory cells","volume":"1","author":"S Meunier","year":"2017","journal-title":"Blood Adv"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0037-1614450","article-title":"Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A","volume":"81","author":"J Qian","year":"1999","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood-2008-04-151597","article-title":"Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response","volume":"113","author":"B Waters","year":"2009","journal-title":"Blood"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2009.03571.x","article-title":"Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A","volume":"7","author":"A Navarrete","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref14","first-page":"290","article-title":"Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells","volume":"142","author":"R Kaczmarek","year":"2023","journal-title":"Blood"},{"issue":"17","key":"ref15","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1182\/blood-2011-08-374645","article-title":"CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice","volume":"119","author":"K N Steinitz","year":"2012","journal-title":"Blood"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"K Shah","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"09","key":"ref17","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1182\/blood.V97.9.2750","article-title":"Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A","volume":"97","author":"G Rossi","year":"2001","journal-title":"Blood"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1016\/j.ymthe.2024.08.023","article-title":"Blunting specific T-dependent antibody responses with engineered \u201cdecoy\u201d B cells","volume":"32","author":"R A Pitner","year":"2024","journal-title":"Mol Ther"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.it.2021.04.006","article-title":"Cytokine-skewed Tfh cells: functional consequences for B cell help","volume":"42","author":"A C Olatunde","year":"2021","journal-title":"Trends Immunol"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","article-title":"Germinal center B cell dynamics","volume":"45","author":"L Mesin","year":"2016","journal-title":"Immunity"},{"issue":"04","key":"ref21","first-page":"568","article-title":"Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients","volume":"88","author":"M T Reding","year":"2002","journal-title":"Thromb Haemost"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"880829","DOI":"10.3389\/fimmu.2022.880829","article-title":"Neutralizing antibodies against factor VIII can occur through a non-germinal center pathway","volume":"13","author":"S R Patel","year":"2022","journal-title":"Front Immunol"},{"issue":"07","key":"ref23","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood-2009-01-200725","article-title":"Lineages of human T-cell clones, including T helper 17\/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses","volume":"114","author":"R A Ettinger","year":"2009","journal-title":"Blood"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1046\/j.1538-7836.2003.00366.x","article-title":"Recognition of coagulation factor VIII by CD4+ T cells of healthy humans","volume":"1","author":"G L Hu","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0037-1612915","article-title":"Mechanism of the immune response to human factor VIII in murine hemophilia A","volume":"85","author":"H Wu","year":"2001","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"S Crotty","year":"2019","journal-title":"Immunity"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"102877","DOI":"10.1016\/j.rpth.2025.102877","article-title":"Exploration of biomarkers for inhibitor development in persons with hemophilia A","volume":"9","author":"M N Fan","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"20","key":"ref28","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/bloodadvances.2019000650","article-title":"Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice","volume":"3","author":"W Jing","year":"2019","journal-title":"Blood Adv"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"112735","DOI":"10.1016\/j.intimp.2024.112735","article-title":"Anti-mCD20 in combination with \u03b1-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia A mice","volume":"139","author":"Q Zheng","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"19","key":"ref30","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood-2009-06-228155","article-title":"CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice","volume":"114","author":"C H Miao","year":"2009","journal-title":"Blood"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"S Dikiy","year":"2023","journal-title":"Immunity"},{"issue":"04","key":"ref32","doi-asserted-by":"crossref","first-page":"e2350506","DOI":"10.1002\/eji.202350506","article-title":"Frequency of natural regulatory T cells specific for factor VIII in the peripheral blood of healthy donors","volume":"54","author":"C Menier","year":"2024","journal-title":"Eur J Immunol"},{"issue":"22","key":"ref33","doi-asserted-by":"crossref","first-page":"e159925","DOI":"10.1172\/JCI159925","article-title":"Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs","volume":"132","author":"J Becker-Gotot","year":"2022","journal-title":"J Clin Invest"},{"issue":"06","key":"ref34","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/pbi.12859","article-title":"Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice","volume":"16","author":"K C Kwon","year":"2018","journal-title":"Plant Biotechnol J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2020.10.009","article-title":"The multifaceted functions of follicular regulatory T cells","volume":"67","author":"P T Sage","year":"2020","journal-title":"Curr Opin Immunol"},{"issue":"08","key":"ref36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1182\/blood.2025029470","article-title":"The T follicular helper\/T follicular helper regulatory pathway in FVIII immune responses in mice","volume":"146","author":"W Jing","year":"2025","journal-title":"Blood"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2005-03-1182","article-title":"High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors","volume":"106","author":"C Hausl","year":"2005","journal-title":"Blood"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/j.1538-7836.2008.03165.x","article-title":"Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells","volume":"6","author":"M Qadura","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/jth.13143","article-title":"Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study","volume":"13","author":"A Antun","year":"2015","journal-title":"J Thromb Haemost"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2015.10.001","article-title":"In vivo induction of regulatory T cells for immune tolerance in hemophilia","volume":"301","author":"X Wang","year":"2016","journal-title":"Cell Immunol"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/jth.12576","article-title":"Long-term tolerance to factor VIII is achieved by administration of IL-2\/IL-2mAb complexes and low dosages of factor VIII","volume":"12","author":"C L Liu","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2012.02.012","article-title":"Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation","volume":"36","author":"A Ballesteros-Tato","year":"2012","journal-title":"Immunity"},{"issue":"06","key":"ref43","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.jtha.2025.02.032","article-title":"An engineered Treg selective immunocytokine induces sustained immune modulation in a preclinical model of hemophilia A","volume":"23","author":"J Rana","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref44","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3324\/haematol.2018.189852","article-title":"Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms","volume":"103","author":"M T Georgescu","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/mt.2011.134","article-title":"Suppression of the immune response to FVIII in hemophilia A mice by transgene modified tolerogenic dendritic cells","volume":"19","author":"R J Su","year":"2011","journal-title":"Mol Ther"},{"issue":"20","key":"ref46","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1182\/blood-2009-05-217315","article-title":"Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy","volume":"114","author":"B Peng","year":"2009","journal-title":"Blood"},{"issue":"08","key":"ref47","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1538-7836.2011.04351.x","article-title":"Tolerance induction to factor VIII by transient co-administration with rapamycin","volume":"9","author":"B Moghimi","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/blood.V95.4.1324.004k25_1324_1329","article-title":"Prevention and treatment of factor VIII inhibitors in murine hemophilia A","volume":"95","author":"J Qian","year":"2000","journal-title":"Blood"},{"issue":"09","key":"ref49","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.ymthe.2021.04.034","article-title":"CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII","volume":"29","author":"J Rana","year":"2021","journal-title":"Mol Ther"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1513009","DOI":"10.3389\/fimmu.2025.1513009","article-title":"CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organs","volume":"16","author":"M Doglio","year":"2025","journal-title":"Front Immunol"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2748-8775.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T23:30:44Z","timestamp":1771371044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2748-8775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2026,2,17]]},"published-print":{"date-parts":[[2026,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2748-8775","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}